Oct 20, 2017
425:414
For every 414 shares held, investors received 425. The price per share adjusted from $3670.00 to $3575.01.
The split itself did not change the total investment value.
Hyundai Pharmaceutical Co., Ltd. (KRX:004310) operates in the Pharmaceuticals: major industry.
Hyundai Pharmaceutical Co., Ltd. company overviewHyundai Pharmaceutical Co., Ltd.'s most recent stock split was on October 20, 2017. It was a 425-for-414 forward split, so shareholders received 425 shares for every 414 they held.
Hyundai Pharmaceutical Co., Ltd. (KRX:004310) has split its stock 5 times: a 11-for-10 split on June 16, 1998, a 83-for-77 split on May 6, 1999, a 11-for-10 split on June 17, 1999, a 10-for-1 split on March 28, 2008, and a 425-for-414 split on October 20, 2017.
Hyundai Pharmaceutical Co., Ltd. has split its stock 5 times. This history records 5 forward splits between June 16, 1998 and October 20, 2017.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hyundai Pharmaceutical Co., Ltd.'s 425-for-414 split on October 20, 2017, every 414 shares became 425 shares.
Hyundai Pharmaceutical Co., Ltd. has not announced a new split in our records. Its most recent split was on October 20, 2017, 9 years ago. Companies announce splits in advance, and any new KRX:004310 split will appear on this page.
Already premium?